BSX Logo

Boston Scientific Corporation (BSX) 

NYSE
Market Cap
$135.02B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
344 of 774
Rank in Industry
47 of 99

Largest Insider Buys in Sector

BSX Stock Price History Chart

BSX Stock Performance

About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and …

Insider Activity of Boston Scientific Corporation

Over the last 12 months, insiders at Boston Scientific Corporation have bought $0 and sold $95.2M worth of Boston Scientific Corporation stock.

On average, over the past 5 years, insiders at Boston Scientific Corporation have bought $2.1M and sold $77.07M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 50,000 shares for transaction amount of $2.1M was made by WICHMANN DAVID S (director) on 2021‑11‑15.

List of Insider Buy and Sell Transactions, Boston Scientific Corporation

2024-11-08SaleEVP, Global Operations
30,580
0.0021%
$87.66$2.68M+0.53%
2024-11-05SaleChairman, President & CEO
162,778
0.0111%
$84.75$13.79M+0.25%
2024-11-01SaleEVP, Human Resources
6,983
0.0005%
$84.33$588,876+5.54%
2024-10-07SaleChairman, President & CEO
162,777
0.0113%
$84.63$13.78M+2.93%
2024-10-07SaleEVP & Group Pres, Cardiology
132,527
0.0092%
$85.00$11.26M+2.93%
2024-10-01SaleEVP, Human Resources
6,983
0.0005%
$83.86$585,594+3.04%
2024-09-05SaleChairman, President & CEO
162,777
0.011%
$81.17$13.21M+3.90%
2024-09-03SaleEVP, Human Resources
6,983
0.0005%
$81.70$570,511+4.13%
2024-08-28SaleEVP & Group Pres, Cardiology
14,132
0.001%
$80.00$1.13M+5.98%
2024-08-26SaleEVP& Grp Pres, MedSurg & APAC
14,012
0.0009%
$79.25$1.11M+5.80%
2024-08-01SaleEVP, Human Resources
6,983
0.0005%
$74.12$517,580+11.50%
2024-07-01SaleEVP, Human Resources
6,983
0.0005%
$77.30$539,7860.00%
2024-06-03SaleEVP, Human Resources
6,983
0.0005%
$75.33$526,029+7.90%
2024-05-29SaleEVP&Pres, Periph Intervent
63,802
0.0043%
$75.10$4.79M+8.22%
2024-05-28SaleEVP& Grp Pres, MedSurg & APAC
14,011
0.001%
$75.34$1.06M+7.62%
2024-05-23SaleEVP and CFO
47,621
0.0033%
$75.11$3.58M+7.89%
2024-05-22SaleEVP and CFO
64,454
0.0044%
$75.91$4.89M+5.92%
2024-05-22SaleSVP, GC and Corp. Secretary
15,006
0.001%
$76.01$1.14M+5.92%
2024-05-21SaleSVP, GC and Corp. Secretary
18,037
0.0012%
$75.60$1.36M+5.30%
2024-05-10SaleEVP & Pres, Eur, Mid-East, Afr
12,931
0.0009%
$74.14$958,717+7.45%

Insider Historical Profitability

2.05%
Mahoney Michael FChairman, President & CEO
1521205
0.1032%
$91.62225+37.05%
LUDWIG EDWARD Jdirector
41374
0.0028%
$91.6212+26.95%
Dockendorff Charles Jdirector
0
0%
$91.6212+35.4%
ABELE JOHN EDirector Emeritus
500000
0.0339%
$91.625212+7.41%
BEST LAWRENCE CEVP
232189
0.0158%
$91.62124<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Fidelity Investments$9.72B9.65141.93M+2.66%+$251.98M0.65
The Vanguard Group$8.73B8.67127.44M+1.58%+$136.16M0.16
BlackRock$8.69B8.63126.84M+0.22%+$18.9M0.19
State Street$4.3B4.2762.73M+0.63%+$26.96M0.18
Massachusetts Financial Services Co Ma$3.19B3.1746.61M-18.48%-$723.87M0.95
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.